Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
about
Activin A directs striatal projection neuron differentiation of human pluripotent stem cellsAge-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington diseaseRole of cerebral cortex in the neuropathology of Huntington's diseaseMouse models of polyglutamine diseases: review and data table. Part IMetabolic disturbances in diseases with neurological involvementMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolismHDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegenerationCorrelations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HDMutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathwayHuman glia can both induce and rescue aspects of disease phenotype in Huntington disease.Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.Rescue of homeostatic regulation of striatal excitability and locomotor activity in a mouse model of Huntington's disease.A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and AmpakinesAngiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model miceAlterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients.Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.Differential electrophysiological changes in striatal output neurons in Huntington's disease.Atg4b-dependent autophagic flux alleviates Huntington's disease progressionChanges in striatal procedural memory coding correlate with learning deficits in a mouse model of Huntington diseaseReduced expression of conditioned fear in the R6/2 mouse model of Huntington's disease is related to abnormal activity in prelimbic cortex.Functional Changes in Neocortical Activity in Huntington's Disease Model Mice: An in vivo Intracellular Study.Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington diseaseThe role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction.Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.Differential Changes in Postsynaptic Density Proteins in Postmortem Huntington's Disease and Parkinson's Disease Human Brains.CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse.Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's diseaseEvidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.Optimising Golgi-Cox staining for use with perfusion-fixed brain tissue validated in the zQ175 mouse model of Huntington's disease.Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's DiseaseStriatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.Endocannabinoid-dopamine interactions in striatal synaptic plasticity.Cell Assembly Dynamics of Sparsely-Connected Inhibitory Networks: A Simple Model for the Collective Activity of Striatal Projection Neurons.
P2860
Q24324143-983159D1-1100-43DD-ADD4-6DD395A67DE4Q24657764-D1A45832-FF55-4166-B2F8-EEA0247EAA32Q26829211-5F3FD991-19A4-4E05-83C2-D69979055547Q26853025-8F65AA7B-0C99-4D2B-BA9C-ACCED36FD970Q26999015-80863A62-0512-4685-BE98-4BC6F801432BQ27005950-7087898F-8D5B-44A7-A8C5-A4B2705E180CQ27309160-B2062B2C-81CF-4486-BC98-E2DAA2220958Q27316520-26F2A571-06A1-4F1E-A18F-C31DBF8EC810Q27332203-88A6973B-7898-43DE-975E-E5C91D4AD81AQ28576523-AB3539EF-4A95-4C0B-8CAA-7D8E62C8AB2AQ30381085-C7065F39-4987-402B-A039-F6C9AE00F383Q30490632-BFDAD37B-083E-41F3-917C-3340D2E0CF87Q30588621-CBC2FB95-24A6-49A2-8AA2-9D563E6A4A95Q30622772-404120E3-7775-4A09-A6B4-C5013FE9012EQ33640604-A9398673-007E-460C-B94D-9C7DDF064471Q33705003-53C93D14-CE0D-4C1D-913C-3541A2DF4B49Q33720370-0E5C931B-0256-4DB6-90D0-6B7D67D9809CQ33781761-40849FD9-AD91-4EF5-9E56-0F14F93C4410Q33923206-3CD51D98-3B3F-48EF-85A2-8D12CC0A3331Q33931283-3EEE63C3-F897-424B-A900-DD5DE097FDCAQ34312581-3A9F74EE-0CA0-4A8E-A2EA-474FA5A6B2A8Q34341619-DE339D1A-E058-4FC2-BE35-D6F337261977Q34764514-D9861941-BB0F-4BDC-BD26-86530B521A57Q34827331-ACFFA815-1F8A-45BE-A6B0-E9833FAF72C1Q35022005-E9D495ED-C275-4251-A15D-41AF8BBF9AD4Q35042882-938A9A0A-A445-494D-B128-C4043DACDCA4Q35055109-809D233F-96D6-4046-AF9B-A288F6263769Q35146890-13BA7A32-7646-4A70-B425-B026984356ADQ35340099-6D76D4AF-F3F7-4298-AB42-C38567C49C98Q35487248-C0FFC7AD-16A5-426E-B801-390E7D39EF63Q35560350-7FBAB1A5-3A79-438A-BAC6-9F44945587A6Q35623502-DF130C80-E961-4862-BD0D-A845C0BD4769Q35703870-394EC3E3-930B-4F2D-A54B-2BD274BEC580Q35706627-04FD3BA7-6090-40E2-A08B-A45FD785E39BQ35754248-A629453B-5554-4883-B0E3-3FBD679C81DFQ35803888-351B5D7D-4129-42CE-80F5-7A40EC5E03A6Q35867178-A58FC235-39C1-4F91-8EEE-408D91EF01F4Q35871006-51653719-C3A5-4799-B7D2-6658019BE3CFQ35898412-799BAFFE-8B0E-4143-B5EA-FC5C2961056AQ35935812-804AB0FA-624C-4950-91D4-BA97BE02448F
P2860
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Electrophysiological and morph ...... ton's disease transgenic mice.
@en
Electrophysiological and morph ...... ton's disease transgenic mice.
@nl
type
label
Electrophysiological and morph ...... ton's disease transgenic mice.
@en
Electrophysiological and morph ...... ton's disease transgenic mice.
@nl
prefLabel
Electrophysiological and morph ...... ton's disease transgenic mice.
@en
Electrophysiological and morph ...... ton's disease transgenic mice.
@nl
P2093
P921
P1476
Electrophysiological and morph ...... ton's disease transgenic mice.
@en
P2093
Chesselet MF
Klapstein GJ
P304
P356
10.1152/JN.2001.86.6.2667
P407
P577
2001-12-01T00:00:00Z